Administration of probiotics and synbiotics and systemic inflammation in Kenyan infants: an open label, randomised, phase II trial
Mary Iwaret Otiti,
No information about this author
Micah J. June,
No information about this author
Alloys K’Oloo
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 4, 2025
Abstract
Environmental
enteric
dysfunction
(EED)
in
early
life,
caused
by
gut
pathogen
colonisation,
contributes
to
chronic
systemic
inflammation
(CSI)
which
impairs
growth
and
organ
development
increases
non-communicable
disease
risk.
Pro/synbiotics
may
prevent
or
ameliorate
EED,
thereby
reduce
CSI,
through
boosting
colonisation
resistance
against
enteropathogens
provide
other
intestinal
immune
benefits.
We
evaluated
three
pro/synbiotics
consisting
of
live,
multi-strain
Bifidobacterium
spp.
Lactobacillaceae
reducing
CSI.
In
this
open-label,
randomised,
four-arm,
phase
II
trial,
600
healthy
Kenyan
newborns
(1–3
days
old,
birthweight
≥2000g)
were
allocated
1:1:1:1,
stratified
HIV
exposure,
receive
Labinic
synbiotic,
Lab4b
synbiotic
probiotic
no
intervention
daily
for
ten
days,
then
weekly
until
six
months.
The
primary
outcome
was
CSI
(plasma
α
1-acid
glycoprotein
>
1g/L)
at
months
with
blinded
laboratory
assessments.
At
months,
occurred
60/138
(43%)
controls
versus
4/144
(3%;
relative
risk
(RR)
0.06,
95%
CI
0.02–0.17;
p
<
0.0001)
infants
the
3/132
(2%;
RR
=
0.05,
0.02–0.16;
P
3/141
0.02–0.15;
arm.
Serious
adverse
events
mortality
over
0–24
similar
across
study
arms.
safely
markedly
reduced
disadvantaged
population,
warranting
investigation
health
impacts.
Language: Английский
Advances in Research on Gut Microbiota and Allergic Diseases in Children
Heng Ke,
No information about this author
Hongbing Yao,
No information about this author
Ping Wei
No information about this author
et al.
Current Research in Microbial Sciences,
Journal Year:
2025,
Volume and Issue:
8, P. 100362 - 100362
Published: Jan. 1, 2025
Epidemiological
studies
indicate
a
rising
prevalence
of
allergic
diseases,
now
recognized
as
major
global
public
health
concern.
In
children,
the
progression
these
diseases
often
follows
"atopic
march,"
beginning
with
eczema,
followed
by
food
allergies,
rhinitis,
and
asthma.
Recent
research
has
linked
gut
microbiota
dysbiosis
to
development
in
children.
The
microbiota,
crucial
component
human
health,
plays
vital
role
maintaining
overall
well-being,
highlighting
its
potential
preventing
modifying
course
diseases.
This
review
examines
relationship
between
childhood
drawing
on
latest
evidence.
We
first
elaborated
concepts
discussion
developmental
trajectory
healthy
further
explored
richness,
diversity,
composition
well
specific
microbial
taxa
associated
disease.
Lastly,
we
discussed
current
status
future
probiotic
interventions
managing
pediatric
Language: Английский
Neonatal microbiome in the multiomics era: development and its impact on long-term health
Pediatric Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 28, 2025
Abstract
The
neonatal
microbiome
has
been
the
focus
of
considerable
research
over
past
two
decades
and
studies
have
added
fascinating
information
in
terms
early
microbial
patterns
how
these
relate
to
various
disease
processes.
One
difficulty
with
interpretation
relationships
is
that
such
data
associative
provides
little
proof
causality
or
underpinning
mechanisms.
Integrating
other
omics
as
proteome,
inflammatory
mediators,
metabolome
an
emerging
approach
address
this
gap.
Here
we
discuss
omics,
their
integration,
they
can
be
applied
improve
our
understanding,
treatment,
prevention
disease.
Impact
This
review
introduces
concept
multiomics
neonatology
technologies
integrated
We
highlight
considerations
for
performing
multiomic
neonates
need
validation
separate
cohorts
and/or
relevant
model
systems.
summarise
use
expanding
lay
out
steps
bring
clinic
enable
precision
medicine.
Language: Английский
Oligosaccharide Production Using β-galactosidase from Lactobacillus bulgaricus and Kluyveromyces lactis in Sweetened Reconstituted Nonfat Dry Milk
Journal of Dairy Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
β-galactosidase
(B-gal)
is
a
vital
enzyme
used
in
the
food
industry
to
reduce
lactose
from
dairy
ingredients
through
hydrolysis
and
synthesize
galacto-oligosaccharides
(GOS),
known
bifidogenic
prebiotic,
galactose
moieties
transgalactosylation.
To
favor
transgalactosylation,
high
carbohydrate
concentrations
must
be
available
accept
moiety.
Since
many
products
rely
on
sweeteners
for
flavor
texture,
B-gal
GRAS
status
Lactobacillus
bulgaricus
strains
LB11,
YB1,
L.
helveticus
B548,
or
Kluyveromyces
lactis
(KL)
commercial
product
Lactozyme®
2600L
were
determine
if
transgalactosylation
can
driven
reconstituted
nonfat
dry
milk
(NDM,
10%,
wt/wt)
with
compared
unsweetened
NDM
at
50°C
18
h.
Sucrose
(14.4%,
wt/wt),
corn
syrup
solids
mixture
of
sucrose
(9.9%,
(4.5%,
dissolved
(n
=
3),
then
heated
stirring
30
min
70°C
batch
pasteurization.
For
strains,
whole
cells
inoculated
7
log
cfu/mL,
same
quantity
lysed
before
adding
mixtures,
1.85
U
KL
was
used.
The
released
highest
glucose
all
preparations,
LB11
lysate
releasing
(245.57
±
25.16
mM).
High-Performance
Anion-Exchange
Chromatography
Pulsed
Amperometric
Detection
visualize
presence
oligosaccharides
degrees
polymerization
3
7.
Oligosaccharides
YB1
treated
mixtures
also
increased
anaerobic
growth
Bifidobacterium
breve
2141
37°C
untreated
mixtures.
treatment
without
source
prebiotic
oligosaccharides,
although
more
work
needed
composition
oligosaccharides.
Language: Английский
The Impact of Probiotic Supplementation on the Development of the Infant Gut Microbiota: An Exploratory Follow-Up of a Randomised Controlled Trial
Niall Coates,
No information about this author
Daniel A. John,
No information about this author
Sue Jordan
No information about this author
et al.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(5), P. 984 - 984
Published: April 25, 2025
Early-life
establishment
of
the
gut
microbiota
plays
a
role
in
lifelong
health,
with
disruptions
linked
to
heightened
risks
metabolic
and
immune
disorders.
Probiotic
supplementation
may
be
used
modulate
infant
microbiome
promote
favourable
development.
Here,
we
evaluate
how
Lab4B
probiotic
shapes
development
over
first
6
months.
Faecal
samples
collected
from
infants
enrolled
PROBAT
(ISRCTN26287422),
randomised,
double-blind,
placebo-controlled
trial,
were
analysed
using
culture-dependent
-independent
(16S
rDNA
metagenomic
shotgun
sequencing)
techniques
examine
composition,
diversity,
capabilities
microbiome,
as
well
abundance
antimicrobial
resistance
genes
(ARGs).
encouraged
distinct
composition
characterised
by
elevated
abundances
Bifidobacteriaceae
weeks
(p
=
0.006)
Lactobacillaceae
throughout
months
<
0.05
at
every
6-week
time
point),
accelerated
microbial
diversification,
reduced
beta-lactam-
cephalosporin-resistance
genes,
differences
predicted
start
end
points.
Supplementation
this
neonatal
population,
which
is
high
risk
atopy,
significantly
influenced
during
Language: Английский
Controllable Enzymatic Synthesis of Natural Asymmetric Human Milk Oligosaccharides
Hsien‐Wei Tseng,
No information about this author
Hsin‐Kai Tseng,
No information about this author
Kai-Eng Ooi
No information about this author
et al.
JACS Au,
Journal Year:
2024,
Volume and Issue:
4(11), P. 4496 - 4506
Published: Nov. 2, 2024
Among
human
milk
oligosaccharides
(HMOs),
linear
HMOs
are
synthesized
through
mature
but
varied
routes.
Although
branched
can
be
by
chemical,
enzymatic,
or
chemoenzymatic
methods,
these
methods
cannot
easily
applied
to
the
synthesis
of
asymmetric
multiantennary
oligosaccharides.
Herein,
we
developed
a
controllable
method
synthesize
biantennary
HMOs.
In
our
synthetic
route,
GlcNAcβ1,3(GlcN3β1,6)Glaβ1,4Glc
was
first
chemically
as
core
tetrasaccharide,
which
contains
β1,6GlcN3
"stop"
sugar
in
transferase-catalyzed
glycosylation.
The
desired
sugars
at
GlcNAcβ1–3Gal
arm
assembled
using
galactosyltransferase,
N-acetylglucosaminyltransferase,
and
fucosyltransferase.
Then,
Staudinger
reduction
acetylation
were
used
transform
GlcN3
GlcNAc
assemble
initiating
"go"
process.
By
manipulating
glycosylations,
22
natural
synthesized.
Language: Английский
Leveraging human microbiomes for disease prediction and treatment
Trends in Pharmacological Sciences,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 1, 2024
Language: Английский
Enhanced metagenomics-enabled transmission inference with TRACS
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 20, 2024
Coexisting
strains
of
the
same
species
within
human
microbiota
pose
a
substantial
challenge
to
inferring
host-to-host
transmission
both
pathogenic
and
commensal
microbes.
Here,
we
present
TRACS,
highly
accurate
algorithm
for
estimating
genetic
distances
between
at
level
individual
SNPs,
which
is
robust
intra-species
diversity
host.
Analysis
well-characterised
Faecal
Microbiota
Transplantation
datasets,
along
with
extensive
simulations,
demonstrates
that
TRACS
substantially
outperforms
existing
strain
aware
inference
methods.
We
use
infer
networks
in
patients
colonised
multiple
strains,
including
SARS-CoV-2
amplicon
sequencing
data
from
UK
hospitals,
deep
population
Streptococcus
pneumoniae
single-cell
genome
malaria
infected
Plasmodium
falciparum
.
Applying
gut
metagenomic
samples
large
cohort
176
mothers
1,288
infants
born
hospitals
revealed
species-specific
rates
their
infants.
Notably,
identified
increased
persistence
Bifidobacterium
breve
infants,
finding
missed
by
previous
analyses
due
presence
strains.
Language: Английский
Non-stochastic reassembly of a metabolically cohesive gut consortium shaped by N-acetyl-lactosamine-enriched fibers
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: Dec. 18, 2024
Diet
is
one
of
the
main
factors
shaping
human
microbiome,
yet
our
understanding
how
specific
dietary
components
influence
microbial
consortia
assembly
and
subsequent
stability
in
response
to
press
disturbances
–
such
as
increasing
resource
availability
(feeding
rate)
still
incomplete.
This
study
explores
reproducible
re-assembly,
metabolic
interplay,
compositional
within
derived
from
pooled
stool
samples
three
healthy
infants.
Using
a
single-step
packed-bed
reactor
(PBR)
system,
we
assessed
reassembly
output
exposed
lactose,
glucose,
galacto-oligosaccharides
(GOS),
humanized
GOS
(hGOS).
Our
findings
reveal
that
complex
carbohydrates,
especially
those
containing
low
inclusion
(~1.25
gL−1)
present
milk,
N-acetyl-lactosamine
(LacNAc),
promote
taxonomic,
under
varying
feeding
rates,
shown
by
diversity
metrics
network
analysis.
Targeted
metabolomics
highlighted
distinct
responses
different
carbohydrates:
was
linked
increased
lactate,
lactose
propionate,
sucrose
butyrate,
CO2,
introduction
bile
salts
with
or
hGOS
resulted
butyrate
reduction
hydrogen
production.
validates
use
PBRs
for
reliably
studying
consortium
functionality
nutritional
disturbances,
offering
insights
into
modulation
their
ecological
dynamics.
Language: Английский
Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants
Raymond Kiu,
No information about this author
Elizabeth M. Darby,
No information about this author
Cristina Alcon‐Giner
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 20, 2024
Abstract
Preterm
infants
(<37
weeks’
gestation)
are
often
administered
broad-spectrum
antibiotics
in
hospitals
due
to
their
vulnerability
severe
morbidity,
including
necrotising
enterocolitis
and
sepsis.
However,
can
disrupt
the
development
of
early-life
microbiota,
potentially
impairing
gut
immunity
colonisation
resistance.
Evidence
shows
that
probiotics
(e.g.,
certain
Bifidobacterium
strains)
may
help
restore
healthy
microbiota.
In
this
study,
we
examined
effects
on
preterm
microbiome
resistome
two
unique
cohorts
34
very-low-birth-weight,
human-milk-
fed
(moderate
very
preterm),
with
one
cohort
receiving
probiotics.
Within
each
group,
some
were
treated
(benzylpenicillin
and/or
gentamicin)
while
others
served
as
non-antibiotic
controls.
We
performed
shotgun
metagenomic
sequencing
93
longitudinal
faecal
samples
from
infants,
generated
>300
metagenome-
assembled
genomes,
obtained
∼90
isolate
genomes
through
targeted
culturomics,
enabling
analysis
microbiome/resistome
at
species
strain
levels.
Additionally,
investigated
vitro
horizontal
gene
transfer
(HGT)
capacity
infant-derived
multidrug-resistant
(MDR)
pathogen
Enterococcus
via
neonatal
models.
Overall,
probiotic
supplementation
significantly
reduced
antibiotic
resistance
prevalence,
MDR
load,
helped
a
typical
persistence
pathogens
like
,
high
HGT
potential,
highlights
need
for
ongoing
surveillance
care.
Our
findings
underscore
complex
interactions
between
antibiotics,
probiotics,
shaping
support
further
research
into
antimicrobial
stewardship
populations.
Language: Английский